Statins as inhibitors of voltage-gated potassium channels Kv1.3 in cancer cells
- 1 April 2021
- journal article
- research article
- Published by Elsevier BV in Journal of Molecular Structure
- Vol. 1230, 129905
- https://doi.org/10.1016/j.molstruc.2021.129905
Abstract
No abstract availableKeywords
Funding Information
- Uniwersytet Medyczny im. Piastów Slaskich we Wroclawiu
This publication has 28 references indexed in Scilit:
- The voltage-dependent K+ channels Kv1.3 and Kv1.5 in human cancerFrontiers in Physiology, 2013
- A fractal approach to dynamic inference and distribution analysisFrontiers in Physiology, 2013
- Role of Kv1.3 mitochondrial potassium channel in apoptotic signalling in lymphocytesBiochimica et Biophysica Acta (BBA) - Bioenergetics, 2010
- Kbgand Kv1.3 channels mediate potassium efflux in the early phase of apoptosis in Jurkat T lymphocytesAmerican Journal of Physiology-Cell Physiology, 2009
- The functional network of ion channels in T lymphocytesImmunological Reviews, 2009
- Potassium channels: New targets in cancer therapyCancer Detection Prevention, 2006
- International Union of Pharmacology. LIII. Nomenclature and Molecular Relationships of Voltage-Gated Potassium ChannelsPharmacological Reviews, 2005
- Differentiation of 3-Hydroxy-3-methylglutaryl-coenzyme A Reductase Inhibitors by Their Relative LipophilicityPharmacy and Pharmacology Communications, 1999
- Calcium-activated potassium channels in resting and activated human T lymphocytes. Expression levels, calcium dependence, ion selectivity, and pharmacology.The Journal of general physiology, 1993
- Time Course of TEA+-Induced Anomalous Rectification in Squid Giant AxonsThe Journal of general physiology, 1966